A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes

Clinical trial NCT02020616 · TERMINATED

Trial details

NCT number: NCT02020616
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2013-12-01
Primary completion: 2015-02-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.